The actions of naloxazone on the binding and analgesic properties of morphiceptin (NH2Tyr-Pro-Phe-Pro-CONH2), a selective mu-receptor ligand.
D000700:Analgesics; D000818:Animals; D001667:Binding, Competitive; D001921:Brain / Q000378:metabolism*; D004723:Endorphins / Q000378:metabolism / Q000494:pharmacology*; D004745:Enkephalins / Q000378:metabolism; D066298:In Vitro Techniques; D007700:Kinetics; D008024:Ligands; D009270:Naloxone / Q000031:analogs & derivatives* / Q000494:pharmacology; D009294:Narcotics / Q000378:metabolism; D051381:Rats; D011957:Receptors, Opioid / Q000378:metabolism*; D017450:Receptors, Opioid, mu
D000700:Analgesics; D004723:Endorphins; D004745:Enkephalins; D008024:Ligands; D009294:Narcotics; D011957:Receptors, Opioid; D017450:Receptors, Opioid, mu; D009270:Naloxone; C024224:naloxazone; C028889:morphiceptin